Controlled Drugs
C - Drug is listed in the Schedule to Part G of the Food and Drug Regulations under the Controlled Drugs and Substances Act N - Drug is listed in the Narcotic Control Regulations under the Controlled Drugs and Substances Act NR - Drug has not been reviewed by the NDSAC PDL - Drug is listed in the Health Canada Prescription Drug List. Some drugs have been reclassified over the years. For example, in 2014, the DEA reclassified the drug hydrocodone, moving it from Schedule III to Schedule II. But on the whole, reclassification or unscheduling a substance is rather rare, and this has led to many controversies surrounding the Controlled Substances Act. Amendment adding drug products in finished dosage formulation that has been approved by the U.S. Food and Drug Administration that contains cannabidiol (2-1R-3-methyl-6R-(1-methylethenyl)-2-cyclohexen-1-yl-5-pentyl-1,3-benzenediol) derived from cannabis and no more than 0.1 percent (w/w) residual tetrahydrocannabinols to Schedule V Effective. Controlled Substances List (Adopted by Alabama State Board of Health on January 20, 2021, effective January 20, 2021) Schedule I (a) Schedule I shall consist of the drugs and other substances, by whatever official name, common or usual name, or brand name designated, listed in this section. Each drug or substance.
What is a controlled (scheduled) drug?
A controlled (scheduled) drug is one whose use and distribution is tightly controlled because of its abuse potential or risk. Controlled drugs are rated in the order of their abuse risk and placed in Schedules by the Federal Drug Enforcement Administration (DEA). The drugs with the highest abuse potential are placed in Schedule I, and those with the lowest abuse potential are in Schedule V. These schedules are commonly shown as C-I, C-II, C-III, C-IV, and C-V. Some examples of drugs in these Schedules are as follows:
- Schedule I — drugs with a high abuse risk. These drugs have NO safe, accepted medical use in the United States. Some examples are heroin, marijuana, LSD, PCP, and crack cocaine.
- Schedule II — drugs with a high abuse risk, but also have safe and accepted medical uses in the United States. These drugs can cause severe psychological or physical dependence. Schedule II drugs include certain narcotic, stimulant, and depressant drugs. Some examples are morphine, cocaine, oxycodone (Percodan®), methylphenidate (Ritalin®), and dextroamphetamine (Dexedrine®).
- Schedule III, IV, or V — drugs with an abuse risk less than Schedule II. These drugs also have safe and accepted medical uses in the United States. Schedule III, IV, or V drugs include those containing smaller amounts of certain narcotic and non-narcotic drugs, anti-anxiety drugs, tranquilizers, sedatives, stimulants, and non-narcotic analgesics. Some examples are acetaminophen with codeine (Tylenol® No.3), paregoric, diazepam (Valium®), alprazolam (Xanax®), propoxyphene (Darvon®), and pentazocine (Talwin®).
In 1981, the Texas Legislature passed a law which required doctors to write all prescriptions for Schedule II drugs on a special three‑part or triplicate form. Effective September 1, 1999, the triplicate prescription form was replaced by an official prescription form. Any triplicate prescriptions that are in use are still valid prescriptions and may be used until the supply is depleted. The new official forms are issued by the Texas Department of Public Safety to prescribers. Pharmacies electronically transmit prescription information to the DPS. The information is used by licensing boards to identify doctors, dentists, and/or pharmacists who may be inappropriately prescribing or dispensing these highly abusable drugs. In addition, the DPS can identify potential abusers much more quickly and stop any abuse, misuse, or diversion in a more timely manner. The program has been very effective in reducing abuse, misuse, and diversion of Schedule II drugs in Texas.
Editor-In-Chief:C. Michael Gibson, M.S., M.D.[1]
Overview
This is a list of Schedule III drugs under the Controlled Substances Act for the United States.Required findings for drugs to be placed in this schedule: [1]
- The drug or other substance has a potential for abuse less than the drugs or other substances in schedules I and II.
- The drug or other substance has a currently accepted medical use in treatment in the United States.
- Abuse of the drug or other substance may lead to moderate or low physical dependence or high psychological dependence.
The complete list of Schedule III drugs are as follows. [2] The Administrative Controlled Substances Code Number for each drug is included.
Schedule 3 Narcotics List Pdf
Stimulants
ACSCN | Drug |
---|---|
1228 | Benzphetamine |
1645 | Chlorphentermine |
1647 | Clortermine |
1615 | Phendimetrazine |
Depressants
ACSCN | Drug |
---|---|
2126 | Amobarbital |
2100 | Any derivative of Barbituric acid |
2510 | Chlorhexadol |
2020 | Embutramide |
2012 | Gamma-Hydroxybutyric acid (for applications under section 505 of Federal Food, Drug, and Cosmetic Act) |
7285 | Ketamine |
7300 | Lysergic acid |
7310 | Lysergic acid amide |
2575 | Methyprylon |
2271 | Pentobarbital |
2316 | Secobarbital |
2600 | Sulfondiethylmethane |
2605 | Sulfonethylmethane |
2610 | Sulfonmethane |
7295 | Tiletamine and zolazepam |
Narcotics
ACSCN | Drug |
---|---|
9803 | Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium |
9804 | Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts |
9805 | Not more than 300 milligrams of dihydrocodeinone (hydrocodone) per 100 milliliters or not more than 15 milligrams per dosage unit, with a fourfold or greater quantity of an isoquinoline alkaloid of opium |
9806 | Not more than 300 milligrams of dihydrocodeinone (hydrocodone) per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active nonnarcotic ingredients in recognized therapeutic amounts |
9807 | Not more than 1.8 grams of dihydrocodeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active nonnarcotic ingredients in recognized therapeutic amounts |
9808 | Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts |
9809 | Not more than 500 milligrams of opium per 100 milliliters or per 100 grams or not more than 25 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts |
9810 | Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts |
9064 | Buprenorphine |
Anabolic steroids
ACSCN | Drug |
---|---|
4000 | Anabolic steroids |
Hallucinogens
ACSCN | Drug |
---|---|
7369 | Dronabinol in sesame oil and encapsulated in a soft gelatin capsule |
References
Drug Scheduling - Dea.gov
- ↑Template:Uscsub retrieved October 2, 2007
- ↑http://www.deadiversion.usdoj.gov/21cfr/cfr/1308/1308_13.htm retrieved October 2, 2007
See also
Template:WikiDoc Sources